329
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Targeting cervical cancer with anti-PD-1 antibodies: what is new?

, , &
Pages 111-114 | Received 29 Oct 2023, Accepted 22 Feb 2024, Published online: 27 Feb 2024
 

Declaration of interest

AD Santin reports grants from Puma, grants from Immunomedics, grants from Gilead, grants from Synthon, grants and personal fees from Merck, grants from Boehringer-Ingelheim, grants from Genentech, grants and personal fees from Tesaro and grants and personal fees from Eisai and R-Pharm U.S.A. The other authors declare no conflict of interest. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was funded in part by grants from NIH U01 CA176067-01A1, the Deborah Bunn Alley Foundation, the Domenic Cicchetti Foundation, the Discovery to Cure Foundation, and the Guido Berlucchi Foundation to AD Santin. This investigation was also supported by NIH Research Grant CA-16359 from NCI and Standup-to-cancer (SU2C) convergence grant 2.0 to AD Santin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.